PROVIDER PROFILE · NPI 1528064912

John NairnM.D.

OphthalmologyWest Mifflin, PAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,772

Unique beneficiaries

—

Total services

2,357

Distinct HCPCS

Medicare payment

$150K

Peer benchmark

Total Medicare services vs. 810 Ophthalmology providers in PA — above median (cohort median 1,854).

PRESCRIBING · PART D · 2024

Total Rx claims

7,734

Beneficiaries

—

Total drug cost

$1.0M

Distinct drugs

Brand share

37.4%

Top prescribed drugs

Latanoprost1,552 claims

Timolol Maleate1,066 claims

Bimatoprost796 claims

Brimonidine Tartrate610 claims

Brimonidine Tartrate/Timolol540 claims

QUALITY · MIPS · 2024

Final MIPS score

82.7

Quality

86.5

Cost

60.7

Improvement activities

40.0

Promoting interop.

94.0

Payment adjustment

0.32%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$537

Payment records

By payment type

Food and Beverage$537

REFERRAL NETWORK

Where John Nairn's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Associates Surgery Centers, Llc Ambulatory Surgical Center · West Mifflin, PA	71	195
Miguel Busquets Ophthalmology · Lexington, KY	40	74
WHEELING HOSPITAL INC	13	32
Jason Bauer Certified Registered Nurse Anesthetist (CRNA) · Pittsburgh, PA	13	27
COSTLOW, JAMES	11	15
ST CLAIR MEMORIAL HOSPITAL	11	22

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history